IntraLase Eye Lasers Continue To Take Share From Microkeratome Blades
This article was originally published in The Gray Sheet
Executive Summary
IntraLase estimates that its FS precision laser will be used in 25% of U.S. corneal flap procedures by next year, up from 16% in the fourth quarter of 2004
You may also be interested in...
AMO To Surround Eye Surgeons With Refractive Offerings After Visx Purchase
Advanced Medical Optics' acquisition of pure-play LASIK manufacturer Visx will enable the combined entity to more effectively market laser eye surgery to physicians performing both refractive and cataract procedures
Eye Laser Company IPO Contends With Microkeratome Competition, Debt
IntraLase Corp. will target its IntraLase FS precision laser to the 1,400 LASIK centers in the U.S. and 4,100 abroad that perform at least 50 procedures per month, the firm says in its IPO prospectus, filed with the Securities & Exchange Commission May 28
Hanmi And LG Chem Highlight Vaccine Prowess, Novel R&D At JPM
Hanmi showcases at JPM its contract production capabilities for COVID-19 vaccines as South Korea prepares to bring in candidates from several global developers, while LG Chem highlights progress across multiple pipeline projects.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: